Join us in San Diego, May 28-31st for the Annual ABFO National Conference

8:45 am to 9:00 am - Welcome/Day 1 Introductions
Brandi Roberts, CFO, ADVENTRX Pharmaceuticals, Inc., 2013 San Diego Conference Chair

9:00 am to 10:00 am - Leadership Strategies – It’s Your Ship
Keynote Speaker: Michael Abrashoff, Former Navy Commander and Author

10:00 am to 10:30 am – Break

10:30 to Noon - Breakout Sessions
Participants will select one breakout session to attend:

Update on IPOs
Moderator: Harry Trout III, Director, Finance, ENATA Pharmaceuticals, Inc.

Current D&O Landscape and Say on Pay
Moderator: Lou Arcudi III, CFO, Idera Pharmaceuticals, Inc.


Frank M. Paolucci, Managing Director, Northeast Region, Aon Financial Services Group - Philadelphia
Jay A. Desjardins, Senior Vice President – Team Leader, Aon Financial Services Group – Philadelphia
Koji Fukumura, Partner, Cooley

Effective Management of Clinical Trials and CROs
Moderator: Brian Baker, Senior Finance Consultant, Cleave Biosciences

Hans-Peter Guler – Sr. VP Clinical Development, Endocrine & Cardiovascular, INC Research
Greg Guarasci - Sr. VP of Clinical Operations, PRA International
Moisha Platto - VP Proposals & Finance, PRA International
David Conway - Sr. Director Clinical Operations, Halozyme Therapeutics

Lean in Biosciences
Moderator: Gary Holden, Director of Information Technology, Vical Inc.

Jorgine Ellerbrock, Sr. Vice President, Operations, Hologic│Gen-Probe
Mike Osterling, Lean Operations Consultant
Lisa Thompson, Associate Director of Lean Enterprise Center of Excellence, Hologic│Gen-Probe
Jerry Wright, Senior Vice President of Lean and Enterprise Excellence, DJO Global

Noon to 1:30 pm – Lunch

1:30 pm to 2:45 pm - State of the Economy
Keynote Speaker: Joe Quinlan, Managing Director & Chief Market Strategist, U.S. Trust, Bank of America, Private Wealth Management

3:00pm to 4:00pm - Which Financing Strategy Is Best For You?

Panel members (“actors”) include: Killu Sanborn, Oxford Finance, Todd Wyche, Brinson Patrick and Doug Marshall, Bank of America

4:00 pm to 6:00 pm Teambuilder – Gaslamp Scavenger Hunt
Participants will be put onto random teams. Let’s see who will do the best as a team and win the grand prize!

6:30 pm – Walk to San Diego Padres Game

THURSDAY, May 30th

8:45 am to 9:00 am - Welcome/Day 2
Introductions Will Waddell, Oncomed, 2014 San Francisco Conference Chair

9:00 am to 10:00 am - Exit Strategies – The Amylin Story
Keynote Speakers: Dan Bradbury, Former CEO, Amylin Pharmaceuticals, Inc. and Mark Foletta, Former CFO, Amylin Pharmaceuticals, Inc.

10:00 am to 10:30 am – Break

10:30 am to Noon - Industry Specific Roundtable Discussions
Participants will select which roundtable discussion they would like to attend based on their company type. Each discussion will have a moderator to keep the conversation moving – participants are encouraged to bring questions!

Early-stage pharmaceuticals
• Late-stage pharmaceuticals
• Commercialized products
• Medical device
• Diagnostics

Noon to 1:30 pm – Lunch

1:30 pm to 2:45 pm - Breakout Sessions
Participants will select one breakout session to attend:

Accounting and SEC Update – led by Ernst and Young

Treasury – Navigating Change – led by Bank of America
From anticipated regulatory changes within the financial services industry to evolving strategies around global operating models, companies faces change and rapid decisioning around every corner. This session will provide finance professionals with a rational approach and insights on how to build a sustainable Treasury platform to meet today’s needs as well as to put the building blocks in place for future success. We will also examine external changes and how to prepare your company to manage these unforeseen conditions that could affect your existing treasury functions.

M&A Considerations
Moderator: Heidi Henson, CFO, Wellspring Biosciences LLC

Troy Wilson, President and CEO, Wellspring Biosciences LLC
Carol Gallagher, Former President and CEO of Calistoga Pharmaceuticals
Kent Hawryluk, Founding Partner CMEA 8, CMEA Capital

The Role of Orphan Drugs in Biotech/Pharma
Today Orphan drugs comprise one of the most sought-after segments of our industry today. Many pharmaceutical companies are seeking to augment their pipeline with them, and venture capital firms are increasingly considering, and making, investments in this subsector. Questions that our panel will explore include: Why? How long will this apparent trend last? What factors will drive pricing for drugs for rare diseases in the changing healthcare environment? Which stakeholders will impact these decisions, and what will be their effect? Our panel is comprised of a venture capitalist, Wall Street research analyst and commercial strategist and pricing expert. They will discuss these questions and the forces that may impact the value that orphan drugs bring to investors and companies, and the resulting future trends that may affect this subsector.
Moderator: Tamara A. Seymour, CFO, HemaQuest Pharmaceuticals, Inc.

Dave Boyden, President and Founder, Mirador Strategies, Inc.
Michael Higgins, Managing Director, Equity Research, Brinson Patrick Securities Corporation
Armen B. Shanafelt, Ph.D., Venture Partner, Lilly Ventures

2:45 pm to 3:00 pm - Break

3:00 pm to 4:00 pm - CFO Fireside Chat
Moderator: BioCentury Editor

Robert Hoffman, Senior Vice President, Finance and CFO – Arena Pharmaceuticals
Phil Schneider, Former CFO, IDEC Pharmaceuticals
Jim Datin, Executive Vice President and Managing Director, Safeguard Scientifics

4:00 pm to 5:00 pm - An Insider’s Guide: What Directors Expect from the CFO Today
Keynote Speaker: Karin Eastham, Board Member – MorphoSys AG, Trius Therapeutics, Illumina, Crosswalk Press LLC, Geron

Today It is no longer enough to bring exceptional technical skills to the CFO position, to produce timely and accurate financial statements and to comply with all the regulatory demands of the job. TODAY the CFO must master the technical skills of the job, implement processes that allow the board to fulfill its obligations to the company AND be an exceptional leader. The CFO must be a "thought partner to the CEO", a participant in crafting the culture of the organization, an active member of the “strategy team”, a partner to the HR executive to observe and drive engagement by the staff of the company and to provide true leadership to the finance team and the organization.

An Insider’s Guide will provide you with tools for effective board preparation, processes that are basic requirements to engage your board and ensure they can “govern” and to be an “enabler” to both your board and your organization. Additionally, tips for effective leadership will be shared based upon lessons learned in the kitchen, in the CFO’s chair and in the boardroom.

5:00 pm to 6:00 pm - Regional Coordinators Meeting

6:15 pm – Leave for Mystery Event


FRIDAY, May 31st

8:45 am to 9:00 am - Welcome/Day 3 Introductions
Brandi Roberts, CFO, ADVENTRX Pharmaceuticals, Inc.,
2013 San Diego Conference Chair

9:00 am to 10:00 am - Recent Developments at the FASB
Keynote Speaker: Larry Smith, FASB Member

10:00 am to 10:15 am – Break

10:15 am to 11:15 am
Keynote Speaker: Dr. Stanley Rockson, Chief of Consultative Cardiology at Stanford University School of Medicine

11:15 am to 11:30 am - Closing Remarks
Brandi Roberts, CFO, ADVENTRX Pharmaceuticals, Inc.,
2013 San Diego Conference Chair

11:30am – Conference Concludes





Up Down